Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Borsa (Milano, Italy), L. Ruiz Iturriaga (Vizcaya, Spain), L. Serrano Fernandez (Vizcaya, Spain), P. España (Galdakao, Spain), S. Aliberti (Milano, Italy), J. Ramirez (Louisville, KY, United States of America), O. Sibila Vidal (Barcelona, Spain), A. Rodrigo Troyano (Barcelona, Spain), A. Rodriguez (Tarragona, Spain), F. Sanz (Valencia, Spain), Y. Shindo (Nagoya, Japan), I. Martin-Loeches (Dublin, Ireland), C. Luna (Buenos Aires, Argentina), D. Stolz (Basel, Switzerland), D. Viasus (Barranquilla, Colombia), J. Carratala (Barcelona, Spain), A. Anzueto (San Antonio, TX, United States of America), M. Restrepo (San Antonio, TX, United States of America). Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events. 3306

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Intrahospital cardiovascular complications in severe community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 Factors associated with community-acquired pneumonia in-hospital mortality in Portugal Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 The problem of early mortality in pneumococcal pneumonia: a study of risk factors Source: Eur Respir J 2015; 46: 561-564 Year: 2015 Biomarkers and cardiovascular events in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Potential causes of increased long-term mortality after pneumonia Source: Eur Respir J 2011; 37: 1306-1307 Year: 2011 Analysis of the mortality caused by community-acquired pneumonia in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 544s Year: 2005 Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Influenza vaccination is associated with reduced severity of community-acquired pneumonia Source: Eur Respir J 2011; 37: 147-153 Year: 2011 Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Comunity acquired legionella pneumonia: cardiovascular events and survival Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006 Affecting factors of mortality in severe community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Obesity is associated with improved survival in community-acquired pneumonia Source: Eur Respir J 2013; 42: 180-187 Year: 2013 Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities Source: Virtual Congress 2021 – Pneumonia Year: 2021